Houston & Bay Town

Discover a New Way to Treat Ulcerative Colitis (UC) – Join Our Clinical Research Study

Are you living with Ulcerative Colitis (UC) and looking for new treatment options? Join us in exploring an innovative way to manage and treat UC. The ABTECT2 Study is focused on evaluating the safety and effectiveness of an investigational medication specifically designed for people with Ulcerative Colitis.

About the ABTECT2 Study

This clinical trial aims to assess a new, investigational treatment for individuals diagnosed with UC. The study is designed to determine how safe and effective this new medication is in reducing symptoms and improving the quality of life for patients with UC.

Why Join the ABTECT2 Clinical Trial?

Participating in this study provides you with the opportunity to:

  • Access new treatment options that are not yet available to the general public.
  • Contribute to medical research, potentially helping to advance care and treatment for UC patients worldwide.
  • Receive expert care and close monitoring by experienced medical professionals throughout the study duration.
  • Participate at no cost, with all trial-related procedures covered.

Who Can Participate?

We welcome a wide variety of participants who meet the following criteria:

  • Age 16 years or older
  • Diagnosed with Ulcerative Colitis
  • Currently experiencing active UC symptoms, even if you’ve tried other treatments before

Your participation can help us better understand how this investigational medication works across different age groups, genders, and health backgrounds.

How to Get Involved

If you want to learn more about the ABTECT2 Study or see if you qualify, contact Inquest Clinical Research and speak with Dr. Naheed Mehki at 832-606-2053. Our team is ready to provide you with all the necessary information and guide you through the screening process.

Take the First Step Today

Don’t miss this opportunity to explore a potential new treatment for Ulcerative Colitis. Your involvement could make a significant impact on future care for UC patients.

 

Connecting with patients and practicing physicians. No insurance is required, and you may be reimbursed for your time and travel expenses.​

Inquest

more>

Why Participate?

Help advance medical research in ulcerative colitis

Gain access to potential new treatment options

Receive care and medical monitoring throughout the study at no cost

Want to Learn More?

To find out more about the ABTECT-2 Study and how to participate, please contact Inquest Clinical Research and speak with Dr. Naheed Mekhri at 832-606-2053.

Together, we can work towards finding new, effective ways to treat ulcerative colitis.

 Those who qualify may receive Reimbursement for study-related travel, study-related care from local doctors, and study medication at no cost.

Inquest

Greater Houston & Bay Town

Clinical Research is currently seeking qualified patients for a number of study opportunities.

Participants in a clinical trial contribute to the development of new therapies while learning about their possible treatments. Our extensive background in academic research provided the roots from which our service has grown. Our research network, which now serves communities all over the country, creates environments where pharmaceutical research proves most effective by tapping into the vast patient resources of our independent-practice physicians.

How can you get onto a trial?

We Appreciate your interest.